attention deficit hyperactivity disorder
Conditions
Interventions
Acupuncture group:Xu's bimanual flying needle therapy
Drug group:Oral Methylphenidate Hydrochloride Prolonged Release Tablets
Sponsors
Shenzhen Bao'an Women's and Children's Hospital
Eligibility
Sex/Gender
All
Age
6 Years to 12 Years
Inclusion criteria
Inclusion criteria: (1) Diagnosed as Attention Deficit Hyperactivity Disorder (ADHD) in children according to ADHD diagnostic criteria in The fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-V). (2)Children between the ages of 6 and 12, regardless of gender, who can persist in treatment for 3 months. (3) The family or guardian of the patient is informed of the study and voluntarily signs an informed consent form. (4) No recent (within 2 weeks) history of using psychoactive substances. (5) Normal vision or normal corrected vision, normal hearing.
Exclusion criteria
Exclusion criteria: (1) Children with severe respiratory, cardiovascular, and hematological diseases, as well as those with coagulation dysfunction. (2) Children with mental retardation, pervasive developmental disorders, childhood mental illness, or neurological disorders. (3) Children who are unable to cooperate with the experiment or unable to understand the operating procedures.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Attention Deficit Hyperactivity Disorder Assessment Scale- Parental Stress Questionnaire;SNAP-IV Attention Deficit Hyperactivity Disorder Rating Scale;Video Electroencephalogram indicators;Event-Related Potential P300 ; | — |
Countries
China
Contacts
Public ContactYunxiang Xu
Guangzhou University of Chinese Medicine; Shenzhen Bao'an Women's and Children's Hospital
Outcome results
None listed